Market Indices
Sector Heatmap
FSGS — First Trust Exchange-Traded Fund VI First Trust SMID Growth Strength ETF
NasdaqFirst Trust Exchange-Traded Fund VI First Trust SMID Growth Strength ETF
- O
- 32.27
- H
- 32.27
- L
- 32.27
- V
- 258.15
FSGS — Latest News & Headlines
10 StoriesA kidney drug could get U.S. patent protection for some uses into October 2037. - Stock Titan
A kidney drug could get U.S. patent protection for some uses into October 2037. Stock Titan
9 of the Best Foods for Focal Segmental Glomerulosclerosis - Everyday Health
9 of the Best Foods for Focal Segmental Glomerulosclerosis Everyday Health
Avoiding Lag: Real-Time Signals in (FSGS) Movement - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (FSGS) Movement news.stocktradersdaily.com
CEO Change Could Be A Key Moment For Travere Therapeutics Stock (TVTX) - Simply Wall Street
CEO Change Could Be A Key Moment For Travere Therapeutics Stock (TVTX) Simply Wall Street
Guggenheim raises Travere Therapeutics stock price target on patent - Investing.com
Guggenheim raises Travere Therapeutics stock price target on patent Investing.com
After two years on a kidney drug, 75% of 12 patients saw urine protein fall to remission levels - Stock Titan
After two years on a kidney drug, 75% of 12 patients saw urine protein fall to remission levels Stock Titan
Vertex Kidney Pill Shows Broader Promise, Lifting Rival Maze 25% - finance.biggo.com
Vertex Kidney Pill Shows Broader Promise, Lifting Rival Maze 25% finance.biggo.com
Travere Therapeutics (TVTX) Secures FILSPARI Patent Extension, Is The Stock A Bargain? - Simply Wall Street
Travere Therapeutics (TVTX) Secures FILSPARI Patent Extension, Is The Stock A Bargain? Simply Wall Street
Travere receives patent allowance for FILSPARI use in FSGS By Investing.com - Investing.com UK
Travere receives patent allowance for FILSPARI use in FSGS By Investing.com Investing.com UK
Travere's CEO plans to step down after nearly eight years. A new leader takes over Dec. 1. - Stock Titan
Travere's CEO plans to step down after nearly eight years. A new leader takes over Dec. 1. Stock Titan